New York files $2 billion lawsuit against J&J for downplaying risks of opioids in its marketing
September 18, 2020Medical Communications new york state, opioid crisis
New York State is suing Johnson & Johnson in a lawsuit seeking $2 billion in damages for the company’s role …
Top Ten most popular articles on Pharmafile.com this week
September 18, 2020Medical Communications
The top ten news stories this week centre around coronavirus vaccines, with Russia signing a deal with an Indian pharma …
Novartis’ Tafinlar/Mekinist combo improves five-year relapse-free survival in new Phase 3 data
September 17, 2020Research and Development Novartis, Tafinlar, mekinist, melanoma
Novartis has unveiled promising new Phase 3 data for its combination of Tafinlar (dabrafenib) with Mekinist (trametinib) in the treatment …
Opdivo scores NICE recommendation in two non-small cell lung cancer indications
September 17, 2020Sales and Marketing NICE, lung cancer, opdivo
NICE has announced its recommendation of Bristol-Myers Squibb’s blockbuster immunotherapy drug Opdivo (nivolumab) for the treatment of two non-small cell …
Oxford University says participant illness that halted its COVID-19 trial may not be linked to the vaccine
September 17, 2020Research and Development coronavirus vaccines, vaccines
The illness of one of the participants in the Oxford-AstraZeneca COVID-19 vaccine trial may not have been caused by the …
US sets out plans to distribute free coronavirus vaccines
September 17, 2020Research and Development
The Trump administration has laid out its strategy to distribute COVID-19 vaccines for free across the US. The Department of …
Independent review finds no evidence of insider trading from Kodak executives before US Government pharma deal
September 17, 2020Business Services
Kodak has been cleared of insider trading by an independent review after one of its top executives bought shares before …
HHS Secretary Alex Azar accused of overruling FDA on COVID-19 test quality reviews
September 16, 2020Research and Development COVID-19, FDA, US, USA
Allegations have emerged accusing US Health and Human Services Secretary Alex Azar of overruling the FDA over the review of …
India signs deal for 100m doses of Russia’s Sputnik V COVID-19 vaccine
September 16, 2020Manufacturing and Production, Research and Development COVID-19, India, Russia, Vaccine
Russia has signed a deal with an Indian pharma firm to test and deliver 100 million doses of its controversial …
Pfizer’s coronavirus vaccine shows moderate side-effects in clinical study
September 16, 2020Research and Development COVID-19, Pfizer, Pfizer vaccine, coronavirus vaccine
Pfizer has said that participants in a late-stage trial for its COVID-19 vaccine candidate have shown mild to moderate side …
Study that alleges COVID-19 was made in a Chinese lab originated from non-profits linked to ex-Trump advisor Steve Bannon
September 16, 2020Research and Development China, Donald Trump, Steve Bannon, Wuhan, coronavirus
A new study that alleges COVID-19 was created in a Chinese lab was published by two non-profits that are linked …
Pharmafile.com’s weekly COVID-19 news round-up
September 16, 2020Research and Development COVID, COVID-19 vaccine, coronavirus
The coronavirus news this week focuses on AstraZeneca’s vaccine candidate, as global trials for itsmuch-hyped vaccine were halted after an …
Lilly’s baricitinib/remdesivir combo lowers recovery time in hospitalised COVID-19 patients, according to new data
September 15, 2020Manufacturing and Production, Research and Development COVID-19, Eli Lilly, pharma, remdesivir
Eli Lilly has unveiled promising new data from a study investigating the efficacy of baricitinib when combined with with Gilead’s …
MSD partners up with Seattle Genetics in two oncology development deals potentially worth over $4bn
September 15, 2020Manufacturing and Production, Sales and Marketing MSD, Seattle Genetics, deal, pharma
MSD has signed two new oncology-based deals with Seattle Genetics which together could be worth up to around $4.4 billion. …
Shionogi launches Fetcroja in the UK for aerobic Gram-negative bacteria infections
September 15, 2020Manufacturing and Production
Shionogi has announced the launch of its new antibiotic in the UK for the treatment of infections due to aerobic …
UK Government’s Chief Scientific Adviser “told off” for advocating for early lockdown
September 15, 2020Manufacturing and Production
Sir Patrick Vallance, the Chief Scientific Adviser to the UK Government, was “told off” for advocating for an early lockdown …
Avantor Clinical Services helps clinical trials stay on track
September 15, 2020Manufacturing and Production
Biopharma and pharmaceutical companies developing treatments and vaccines have long faced operational challenges that cost time and money while draining …
Oncology research in the age of COVID-19
September 14, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, feature, pharma
Matt Fellows investigates the new challenges facing the oncology space and explores the strategies that can carry it through the disruptive …
AstraZeneca and Oxford Uni’s COVID-19 vaccine trial resumes following safety review
September 14, 2020Research and Development, Sales and Marketing AstraZeneca, COVID-19, Oxford University, Vaccine
After sparking a wave of concern through industry and mainstream media with the news it had halted international studies investigating …
Gilead scoops up Immunomedics in deal worth $21 billion
September 14, 2020Sales and Marketing Gilead, Immunomedics, acquisition, pharma
The Board of Directors from both companies have unanimously agreed for Gilead to acquire Immunomedics for $88 per share in …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
